These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32554563)

  • 1. Targeting GLUT1 in acute myeloid leukemia to overcome cytarabine resistance.
    Åbacka H; Hansen JS; Huang P; Venskutonytė R; Hyrenius-Wittsten A; Poli G; Tuccinardi T; Granchi C; Minutolo F; Hagström-Andersson AK; Lindkvist-Petersson K
    Haematologica; 2021 Apr; 106(4):1163-1166. PubMed ID: 32554563
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy. The Japan Adult Leukemia Study Group.
    Miyawaki S; Kobayashi T; Tanimoto M; Kuriyama K; Murakami H; Yoshida M; Minami S; Minato K; Tsubaki K; Omoto E; Oh H; Jinnai I; Sakamaki H; Hiraoka A; Kanamaru A; Takahashi I; Saito K; Naoe T; Yamada O; Asou N; Kageyama S; Emi N; Ueda T; Tomonaga M; Ohno R
    Int J Hematol; 1999 Jul; 70(1):56-7. PubMed ID: 10446497
    [No Abstract]   [Full Text] [Related]  

  • 3. Sense and nonsense of high-dose cytarabine for acute myeloid leukemia.
    Löwenberg B
    Blood; 2013 Jan; 121(1):26-8. PubMed ID: 23287624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A microarray study of altered gene expression after cytarabine resistance in acute myeloid leukemia.
    Yin B; Tsai ML; Hasz DE; Rathe SK; Le Beau MM; Largaespada DA
    Leukemia; 2007 May; 21(5):1093-7. PubMed ID: 17301810
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytarabine dose in the consolidation treatment of AML: a systematic review and meta-analysis.
    Magina KN; Pregartner G; Zebisch A; Wölfler A; Neumeister P; Greinix HT; Berghold A; Sill H
    Blood; 2017 Aug; 130(7):946-948. PubMed ID: 28679736
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-dose cytarabine and hypomethylating agents for Down syndrome with acute myeloid leukemia.
    Ramakrishnan R; Munir F; Quesada AE; Hitzler J; Cuglievan B
    Pediatr Blood Cancer; 2024 Jun; 71(6):e30974. PubMed ID: 38523255
    [No Abstract]   [Full Text] [Related]  

  • 7. Occurrence and therapy of secondary acute myeloid leukaemia in two HIV-infected patients.
    Hengge UR; Schultewolter T; Uppenkamp T
    AIDS; 1998 Jan; 12(2):221-2. PubMed ID: 9468375
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimal dosing of cytarabine in induction and post-remission therapy of acute myeloid leukemia.
    Walter RB; Appelbaum FR; Estey EH
    Leukemia; 2021 Feb; 35(2):295-298. PubMed ID: 33328603
    [No Abstract]   [Full Text] [Related]  

  • 9. High-dose cytarabine induction for acute myeloid leukemia.
    Shepherd JD; Barnett MJ; Philips GL
    Blood; 1996 Jul; 88(2):754-5. PubMed ID: 8695826
    [No Abstract]   [Full Text] [Related]  

  • 10. Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the Study Alliance Leukemia.
    Müller-Tidow C; Tschanter P; Röllig C; Thiede C; Koschmieder A; Stelljes M; Koschmieder S; Dugas M; Gerss J; Butterfaß-Bahloul T; Wagner R; Eveslage M; Thiem U; Krause SW; Kaiser U; Kunzmann V; Steffen B; Noppeney R; Herr W; Baldus CD; Schmitz N; Götze K; Reichle A; Kaufmann M; Neubauer A; Schäfer-Eckart K; Hänel M; Peceny R; Frickhofen N; Kiehl M; Giagounidis A; Görner M; Repp R; Link H; Kiani A; Naumann R; Brümmendorf TH; Serve H; Ehninger G; Berdel WE; Krug U;
    Leukemia; 2016 Mar; 30(3):555-61. PubMed ID: 26522083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics as predictive marker for consolidation therapy with high-dose cytarabine in acute myeloid leukemia.
    Schlenk RF
    Haematologica; 2024 Jun; 109(6):1629-1630. PubMed ID: 38832418
    [No Abstract]   [Full Text] [Related]  

  • 12. Facts about FCE (fludarabine, cytarabine, etoposide) in acute myeloid leukemia.
    Medeiros BC
    Acta Haematol; 2014; 131(4):200-1. PubMed ID: 24296429
    [No Abstract]   [Full Text] [Related]  

  • 13. [Klinefelter syndrome and acute myeloblastic leukaemia].
    Bellaaj H; Sandi HS; Kammoun H; Kallel C; Kassar O; Elloumi M
    Presse Med; 2009 Jun; 38(6):1019-22. PubMed ID: 19167185
    [No Abstract]   [Full Text] [Related]  

  • 14. [Observation and care in high-dose cytarabine treatment of acute myelogenous leukemia].
    Xi YR; Tu YL; Zhao XH
    Zhonghua Hu Li Za Zhi; 1996 Nov; 31(11):653-5. PubMed ID: 9304928
    [No Abstract]   [Full Text] [Related]  

  • 15. Concentrative nucleoside transporter 3 as a prognostic indicator for favorable outcome of t(8;21)-positive acute myeloid leukemia patients after cytarabine-based chemotherapy.
    Song JH; Cho KM; Kim HJ; Kim YK; Kim NY; Kim HJ; Lee TH; Hwang SY; Kim TS
    Oncol Rep; 2015 Jul; 34(1):488-94. PubMed ID: 25955569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Petechiae, suffusions and cytarabine-induced erythema in treatment of acute myeloid leukemia].
    Taverna C; Jacky E; Sauter C
    Schweiz Med Wochenschr; 1998 Jul; 128(27-28):1117. PubMed ID: 9691347
    [No Abstract]   [Full Text] [Related]  

  • 17. Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia.
    Liu J; Mi Y; Fu M; Yu W; Wang Y; Lin D; Bian S; Wang J
    Am J Hematol; 2009 Jul; 84(7):422-7. PubMed ID: 19484734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics of cytarabine in childhood leukemia.
    Lamba JK
    Pharmacogenomics; 2011 Dec; 12(12):1629-32. PubMed ID: 22118048
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapy: Lo and behold, a role for lomustine in acute myeloid leukemia?
    Appelbaum FR
    Nat Rev Clin Oncol; 2010 Nov; 7(11):619-21. PubMed ID: 20981126
    [No Abstract]   [Full Text] [Related]  

  • 20. Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia.
    Degwert N; Latuske E; Vohwinkel G; Stamm H; Klokow M; Bokemeyer C; Fiedler W; Wellbrock J
    Eur J Haematol; 2016 Sep; 97(3):239-44. PubMed ID: 26613208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.